Stay updated on Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.

Latest updates to the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe study record page now shows a 403 Forbidden message and a Home link; the site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.6%

- Check21 days agoChange DetectedThe 403 error page and its Home link are no longer displayed; the study record content is not visible.SummaryDifference0.5%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error with the site chrome, preventing the study record from being viewed. The surrounding study-related content appears removed or hidden, leaving only the error context.SummaryDifference19%

- Check56 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, representing a minor update to the site's underlying versioning.SummaryDifference0.0%

- Check77 days agoChange DetectedA new revision number was added, updating from v3.6.4 to v3.6.5. This indicates a minor update to the page's content or metadata rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.